Share Email Print
cover

Proceedings Paper

Laser sclerectomy and 5-FU controlled-drug-release biodegradable implant for glaucoma therapy
Author(s): Franck L. Villain; Jean-Marie A. Parel; Katalin Kiss; Richard K. Parrish; Francois Kuhne; Yoshiko Takesue; Patrick Hostyn
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Laser sclerectomy, a simple filtering procedure performed to alleviate high intraocular pressure in glaucoma patients, was taught to offer longer lasting effect and therefore improve the patient's outcome when compared with the standard trabeculectomy procedure. Recent clinical trials have shown that this was not the case and pharmacologic wound healing modulation is also required with this new procedure. Five-Fluorouracil (5-FU) is useful as an adjunct treatment for glaucoma filtering surgery. However, efficacy depends upon maintaining sustained drug levels, currently achieved by repeated daily injection of the drug for several weeks. To overcome this limitation, we designed a biodegradable implant for the sustained release of 5-FU. After laser sclerectomy, the implant is inserted through the same 1 mm wide conjunctival snip incision and positioned below the open channel. Implantation takes less than a minute. The implant releases the drug for over 15 days and totally biodegrades in less than 100 days. The combined laser surgery and implantation procedure show great potentials for the treatment of glaucoma.

Paper Details

Date Published: 24 June 1993
PDF: 5 pages
Proc. SPIE 1877, Ophthalmic Technologies III, (24 June 1993); doi: 10.1117/12.147533
Show Author Affiliations
Franck L. Villain, Bascom Palmer Eye Institute/Univ. of Miami School of Medicine (United States)
Jean-Marie A. Parel, Bascom Palmer Eye Institute/Univ. of Miami School of Medicine (United States)
Katalin Kiss, Bascom Palmer Eye Institute/Univ. of Miami School of Medicine (United States)
Richard K. Parrish, Bascom Palmer Eye Institute/Univ. of Miami School of Medicine (United States)
Francois Kuhne, Bascom Palmer Eye Institute/Univ. of Miami School of Medicine (USA), and Univ. of Bordeaux II (France)
Yoshiko Takesue, Bascom Palmer Eye Institute/Univ. of Miami School of Medicine (USA), and Fukuoka Univ. (Japan)
Patrick Hostyn, Bascom Palmer Eye Institute/Univ. of Miami School of Medicine (USA), and Univ. of Bordeaux II (France)


Published in SPIE Proceedings Vol. 1877:
Ophthalmic Technologies III
Jean-Marie A. Parel; Qiushi Ren, Editor(s)

© SPIE. Terms of Use
Back to Top